Open Access

Facial Diffuse Plexiform Neurofibroma-associated Mandibular Deformities: Surgical Interventions and Monitoring of Treatment Results in a Patient for Over 40 Years

REINHARD E. FRIEDRICH 1*
FELIX K. KOHLRUSCH 1*
  &  
CHRISTIAN HAGEL 2
*These Authors contributed equally to this work

1Department of Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany

2Institute of Neuropathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany

Cancer Diagnosis & Prognosis May-June; 5(3): 319-329 DOI: 10.21873/cdp.10444
Received 15 January 2025 | Revised 07 February 2025 | Accepted 11 February 2025
Corresponding author
Professor R.E. Friedrich (ORCID: 0000-0001-7747-9636), MD, DMD, PhD, FEBOMFS, Department of Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Martinist. 52, 20246 Hamburg, Germany. e-mail: rfriedrich@uke.de
pdf image icon

Abstract

Background/Aim
Neurofibromatosis type 1 (NF1) is an autosomal dominant hereditary tumor-predisposition syndrome and a genetic bone disease. The case report describes tumor-associated mandibular changes, their therapy and follow-up over several decades. The aim of the presentation is to highlight the tumorous and hamartomatous components of the facial skeleton and to examine the stability of surgical measures over the long term.
Case Report
A 13-year-old male patient had developed an extensive diffuse plexiform neurofibroma of the left cheek and neck region. Radiological examination showed a mandibular defect, which enlarged over time. Surgical treatment consisted of a corrective procedure for the asymmetrical bony chin and augmentation osteoplasty of mandibular defect. The transplant was an integral part of a functionally stable bone for decades.
Conclusion
Head and neck diffuse plexiform neurofibroma can be associated with craniofacial bone malformations. Distinction between deformity-related bone changes from an infiltrating and destructive tumor can be difficult, especially in cases of rapidly progressive local bone loss. Presumably, both tumor-associated functional lesions of the masticatory muscles and tumor-related effects on the bone influence the shape of the affected bone. Diagnosis of tumor-associated bone lesions can be challenging in NF1. Reconstructive bone surgery of the jaw provides options for functional and esthetic improvement of the affected individual. However, long-term follow-up checks are advisable to assess treatment results. An exact assessment of the tumor type and long-term monitoring of the findings are the basis of a viable surgical therapy.
Keywords: Neurofibromatosis type 1, mandible, osteoplasty, plexiform neurofibroma, bone dysplasia

Introduction

Neurofibromatosis type 1 (NF1) is an autosomal dominant heritable tumor suppressor gene disease. With a frequency of approximately one in 2500 live births, NF1 is the most common hereditary disease, with a predisposition for the development of cancer. NF1 is characterized by tumors that originate in nerve sheath cells. Schwann cells or their precursors are considered tumor cells of origin in neurofibroma. The NF1 gene product, neurofibromin, has important, however largely unknown, functions in the development of tissues and organs, including bone. The best-studied function of neurofibromin is its involvement in the functional control of the rat sarcoma (RAS) gene (1).

In the cranial region, characteristic but variable disorders of bone are frequently recorded, which in many cases are topographically associated with a type of neurofibroma almost exclusively developing in NF1, the diffuse plexiform neurofibroma (DPN) (2). These tumors can have a considerable impact on the physical appearance of the patient through invasive and destructive growth (2). DPN is considered a congenital tumor that can cause conspicuous changes to the face during prenatal development or shortly after birth. Facial DPN (FDPN) typically develops on one side of the face. Tumor-associated changes in the jaws are limited to the tumor side (3,4). The DPN can be assigned to the terminal branches of the trigeminal nerve (5), usually defined by clinical assessment of the tumor’s extension in the facial skin (6). If the tumor manifests in all three branches, a hemi-FDPN may develop, which alters the affected face in stark contrast to the unaffected half of the face. The bony changes can be distinct and may initially escape notice due to the voluminosity of soft-tissue tumor but significantly determine both physical expression and functional orofacial performance (7). Tumor-side hypoplasia of the jaws determines the skeletal phenotype, which is particularly noticeable in the lower jaw (3,7). Local jaw hyperplasia in NF1 is rarely described (8,9). The topographical association of jaw lesions with DPN has been repeatedly documented (8,9). Alterations of jaw size and shape are assessed to be largely stable in cases of FDPN in adults (10). In contrast to the assessment of stable bone shapes in adulthood, individual courses have demonstrated further deformation and degradation of bone in close contact with an invasive nerve sheath tumor over time in young patients (10). Indeed, extensive FDPN can occasionally cause the complete destruction of the ramus and jaw angle (11-13).

This report contributes to the knowledge on deforming and osteolytic facial skeletal pathology of patients with NF1, a disease which frequently develops in topographical association with a neurogenic neoplasm. This is suspected to be a preliminary stage of malignant disease of the peripheral nerves. We detail the course of the disease over more than 40 years using an example of FDPN-associated mandibular dysplasia and reveal the influence of surgical measures on bone shape, regeneration, and adaptation in a tumorous soft-tissue environment. The case is illustrated by the sequential presentation of radiological findings (Figure 1, Figure 2, and Figure 3) and the comparison of the external aspect over time (Figure 4).

Case Report

The male patient first attended the Clinic for Oral and Craniomaxillofacial Surgery at the age of 13 years. At that time, a diagnosis of NF1 had already been established (Recklinghausen’s neurofibromatosis). The child's examination was aimed at assessing the tumor on the left side of the head and neck region, which primarily affected the supraclavicular to the pinna region. Additional radiological imaging of the lower jaw revealed the rarefaction of the bone around the left jaw angle (Figure 1A). The radiograph depicted a deepened coronoid notch, an increased transparency of the ramus between the coronoid notch and above the mandibular foramen, giving the impression of an enlarged mandibular foramen, plus a roundish notch at the angle of the jaw with transition to the ramus. At that time, there was no indication for surgical intervention. The panoramic radiograph (PR) taken 1 year later showed the notch at the angle of the jaw and the narrowing of the condylar process on the tumor side (Figure 1B). The antegonial notch had increased in size; in other words, the bone had lost substance in the antegonial notch region. In contrast, the outermost angle of the jaw adjacent to the dorsal notch was elongated like a hook. PRs showed the asymmetrical development of the bony chin (Figure 1B and C). At the age of 18 years, the patient decided to undergo genioplasty to make the chin appear less prominent and asymmetric. The healing process following osteotomy was unremarkable. At that time, further angular osteolysis in the area of the antegonial notch was documented (Figure 1D).

The patient did not appear for a check-up until 13 years later. The now 31-year-old patient had an atrophic cheek on the tumor side, a caudally sunken ear, and skin covered by multiple cutaneous neurofibromas (Figure 4A). The facial aspect confirmed the extension of the DPN from the left infraorbital region to the clavicle. The chin was covered by a prominent palpable spongy soft-tissue tumor. The left, more voluminous, parts of the chin tumor were located at the side where the lower edge of the chin extended further caudally. The soft-tissue tumor continued with the left-sided cheek tumor, extended distally to the pinna and covered the skin above the clavicle caudally. The PR of the jaws showed the sharply marked and slightly enlarged, wedge-shaped destruction of the bone anterior to the left mandibular angle (Figure 1E). The facial asymmetry was obviously the combined result of facial muscle atrophy due to progressive tumor infiltration, the effects of gravity in the tumor area on soft tissue (cheek, pinna), and bone deformity (Figure 2 and Figure 4). However, the corrected chin region was unchanged from the postoperatively documented contour, compared in transversal and sagittal planes (Figure 1 and Figure 2). On the other hand, the chin osteoplasty was no longer distinguishable from the rest of the bone on subsequent X-ray examinations (Figure 1E).

Because the lower jaw had extremely thinned in the left angular region (Figure 1E) and a reactive, load-resistant reinforcement of the internal trabecular structure of the remaining bone to increase the bending strength could not be determined from the x-rays, augmenting osteoplasty was performed to seal the defect (iliac crest autograft) (Figure 1F; Figure 3C and D). Subsequently, the graft, which had grown into the bone and was intrinsically modeled, remained dimensionally stable (Figure 1I). The healing process was unremarkable. Further follow-up checks documented the complete integration of the graft into the mandibular bone. However, there was considerable lateral resorption of the bone graft during the following years (Figure 1G and H; Figure 3D and E). The resorption of the graft had caused the screw heads to protrude above the level of the vestibular bone surface and they were palpable during the follow-up. The discomfort of the protruding screws justified their removal at 5 years after transplantation (Figure 2E). The distal screw was firmly ingrown in the bone and could not be loosened without ablation of the surrounding bone and was therefore removed at the bone level (Figure 2E). Again, the healing process was unremarkable.

During the following years, surgical interventions to reduce the prominent soft-tissue masses were repeatedly performed. Further follow-up over 20 years showed the involution of the alveolar process after tooth loss and discrete resorption of the lower edge of the mandible on the left side, which transposed the external mandibular angle slightly cranially (Figure 2F and G). The bone graft fitted into the shape of the bone in all dimensions. The transplant merely followed the minor basal resorption of the bone (Figure 1I and Figure 2G). The articular process and coronoid notch had hardly changed when comparing the initial findings in adolescence (Figure 1A-D) with the x-ray findings of the elderly patient (Figure 2G). The hypoplasia of the ramus had remained largely unchanged since the examination at the time of bone augmentation, as had the contour of the surgically modeled chin.

Three-dimensional imaging of the bone on cone-beam computed tomograms showed that the enlargement of the mandibular foramen on the PR corresponded to a cup-like hollowing of the lingual side of the bone with deformation of the thin ramus (Figure 2A and B). On the PR taken during adolescence and early adulthood, the thinned, shell-like curved ramus may have been partially located outside the focal trough of the device due to the deformation, thus creating the impression of an enlarged foramen. The tomograms taken later show the shell-like thinning of the ramus, which appears on the PR as a tumor-associated enlargement of the mandibular foramen (Figure 1; Figure 2A, B, and E-G).

At the age of 61 years, the patient developed a left-sided submandibular swelling in the anterior part of the FDPN within a short period of time. The ultrasound examination showed an oval-shaped, low-echoic mass that was compressible. This finding was difficult to distinguish sonographically from a diffuse neurofibroma or rapidly growing tumor. However, the swelling showed no functional limitations or complaints. The suspicion of subcutaneous hemorrhage originating from diffuse neurofibroma was confirmed in the follow-up, during which the mass resorbed after 4 weeks. In addition, magnetic resonance imaging (MRI) of the head and neck region was performed. The imaging revealed a significantly enlarged left internal jugular vein in a tumor mass that included the parotid gland and the musculature around the mandibular processes and coronoid notch. The extensive dissolution of the barely visible masticatory muscles of the affected side was striking, as illustrated by the comparison with the unaffected opposite side (Figure 2C and D).

The following findings of the aged patient are conspicuous from the summary of the radiological diagnostics during the follow-up (Figure 2): the left mandibular foramen was now located further caudally than the right one on PR (hollowing of the lingual ramus side). However, the left outer jaw angle was slightly displaced cranially because of bone resorption. The left mental foramen had a larger diameter than the right one. This finding had no correlation to the terminal extent of the nerve canal on each side: On PR, the mandibular canalis incisivus could be traced on both sides up to the lateral incisors and had the same diameter and mesial spread on both sides (Figure 1, Figure 2, and Figure 3). The mandibular left collum with articular process was narrowed, yet the coronoid notch was not deepened (Figure 1). However, the vertical loss of ramus height and the significant thinning of the ramus were constant findings into old age (Figure 1, Figure 2, and Figure 3). The left glenoid fossa had flattened. The antegonial notch (attachment region for the masseter muscle) was missing on the left side and the augmented bone showed no resorption resembling the bone loss of youth (which is interpreted as a defect aligned perpendicular to the basal bone line of the body). The basal cortical of the mandible was poorly defined on the tumor side. The atrophy of the alveolar process of the left side after tooth loss appeared symmetrical in lateral comparison of the mandible (Figure 2F). The chin was symmetrical in shape and showed no increase in vertical dimension almost 40 years after genioplasty (Figure 2G). Assessing facial bones and soft tissues beyond the jaws, the orbital region was symmetrically developed, and the soft-tissue auditory canal of the left side was bent more caudally in accordance with the caudal displacement of the pinna. Figure 4 illustrates the external clinical findings of the adult over time.

Histology. The intra-operative aspect of the primary tumor at the age of 31 years was that of a diffuse plexiform neurofibroma. However, histology identified only a diffusely infiltrating neurofibroma in the most recent operation at the age of 53 years (World Health Organization grade I).

Discussion

This report indicates that both ablative and augmentative skeletal procedures of the mandible can remain stable for decades, with adaptive changes in the affected bone occurring in alignment with the contour of the organ.

Progression of disease-characteristic findings in NF1. NF1 is a chronic progressive disease. The progression of the disease is easily recognizable by the very frequent increase in number and size of cutaneous neurofibromas as a function of age (Figure 4). Cutaneous neurofibromas typically appear during or after puberty, are limited in diameter to a maximum of a few centimeters and can develop in very variable numbers and skin regions throughout life. According to current estimates, these tumors only develop at the time of puberty and do not grow infiltratively in muscle or bone (1,5). These tumors are not expected to change the shape of the jaw.

Disease-characteristic skeletal changes can show an aggravation of the findings over time, for example kyphosis of the spine or non-union of long bones. However, in these distortions of the axial skeleton, the association with a DPN is frequently noted, but not an obligatory finding (14,15). On the other hand, jaw malformation in patients with NF1 usually indicates adjacent DPN (3,11-13). The bone changes can have a predilection for a progressive course, particular during the early phases of life (16-18).

Latency and progression of craniofacial bone findings in NF1. For the skull, enlargement of defects, growing of a tumor, and aggravations of the local findings, especially exophthalmos, have also been described using the example of diagnostically groundbreaking dysplasia of the sphenoid bone (19). The revised classification of the diagnostic criteria of NF1 corrects the finding of sphenoid dysplasia as usually being dependent on an orbital DPN. The skeletal diagnostic criterion is now only included in the diagnosis if the finding has been confirmed without evidence of topographically associated DPN (20). The analogy to the jaw findings in NF1 is obvious. In most cases, the bone findings, especially in the regions of the mandible close to the joint, are associated with a DPN. The skeletal changes may be indicative of DPN, although the tumor may escape advanced imaging and only be detected by surgical exploration (21).

Dysmorphia of the lower jaw is considered a comparatively stable finding in adult patients with NF1 (10). One-sidedness of the findings is a frequently noted feature of the mandibular dysplasia. The association with a DPN on the same side has been widely documented (3,4,6,7,13). However, some reports documenting extensive loss of parts of the mandible indicate that these patients do not necessarily have to have a stable skeletal condition (13). The walling of the resorbed ramus and distal mandibular angle by the DPN has been described in detail clinically and on MRI in these cases (13). However, complete mandibular resorption in FDPN cases with large tumor mass surrounding the mandible is not an inevitable fate of the affected bone segment. In most patients with extensive FDPN, follow-up examination of the severely dysmorphic mandibular side reveals a stable bone shape or only minor progress of dysplasia beyond childhood (10). It can therefore only be assumed that additional factors cause the dissolution of the bone, for example tumor-associated destruction of the masticatory muscles at the site adhering to the ramus due to loss of shear stress on the bone, disorders of the bone's vasculature causing malnutrition, or the pathogenetically largely undefined stimulation of osteoclasts in NF1 (14-18).

In the case reported here, the osteotomy of the chin region remained stable for decades. Likewise, the diffuse neurofibroma of the chin remained largely stable and only showed very slow, visible increase in volume, which accentuated the chin region asymmetrically and justified minor surgical interventions (Figure 2 and Figure 4). The increases in tumor volume may be due to both a discrete increase in the number of tumor cells and the extracellular matrix, as well as to the effects of gravity on the tumor-infiltrated soft tissue of chin, which lacks normal, shape-maintaining connective tissue (22,23).

Pathogenesis of bone deformity associated with muscle disease. The bone defect of the jaw angle was adjacent to the insertion of some masticatory muscles. It remains speculative whether the sharply defined resorption of the basal bone part had a correlation with a dystrophic muscle part, e.g., the masseter muscle. MRI of the jaws taken at the same time showed infiltration of the pterygoid muscles and masseter.

However, the destruction of the skeletal muscles in the perimandibular area did not affect the muscles in the same way. While an at least partially dimensionally stable lateral pterygoid muscle was present on the tumor-side articular process for decades, the signal intensity of which corresponded to the same muscle on the opposite side, neither the shape nor signal of the medial pterygoid muscle was detectable in the lingual insertion area (Figure 2). While the articular process had largely developed normally, hypoplasia of the ramus with a shell-like defect had formed around the mandibular foramen. It is likely that the altered masticatory muscles in the tumor region had an influence on the bone shape. This effect of a degenerated musculature on the mandible, in particular the ramus and articular process, is apparently particularly notable in childhood and adolescence. In the case presented, the somewhat thinner articular process remained unchanged during the examination interval, i.e., it was already detectable during puberty. In contrast, although the defect of the mandibular angle was detectable at the same time, the conspicuous triangular defect did not develop until several years later. It is possible that degeneration of the masticatory muscles is associated with bone remodeling and that the early phase of life is particularly susceptible to this metamorphosis. Similarly, the metachronous course of bone remodeling (early narrowing of the articular process, larger defect of the mandibular angle a few years later) gives rise to the assumption that muscle degeneration also begins at different times and can be self-limiting. However, the correlation of retention or loss of bone shape of the process and ramus area depending on the detection of the skeletal muscles in imaging cannot explain why the bone graft of the antegonial notch was not completely resorbed. Surrounded by a tumorous environment, the avascular transplant underwent noticeable resorption. However, bone loss only affected the parts that protruded laterally beyond the contour of the bone. The bone embedded in the triangular defect was preserved over the following three decades, staying permanently in close contact with the tumor-infiltrated soft-tissue layer.

The soft-tissue layer (cheek) appeared hypoplastic when compared from side to side. Considering the photographic documentation of the patient’s face at the time of jaw augmentation (Figure 4A), it is evident that the cheek hypoplasia already existed at this time and remained largely stable during the observation period (Figure 4B). In many cases, a strong increase in the volume of the FDPN is noticeable and the tumor side appears significantly larger than the unaffected side (7).

Frequency of mandibular deformity in NF1. These are rare findings in NF1 and analyses of jaw changes in a larger number of patients are biased by the referral characteristics of specialized clinics (3), so that generalizations about the frequency of jaw deformities can only be drawn from a few reports to date. However, the methodological tools used in the studies rarely focus on comprehensive craniofacial diagnostics.

In Crowe et al. ’s evaluation of clinical findings from 75 patients (25) [which come from the radiological case collection of Holt and Wright (25)] who had bony malformations, the authors described five children (6.7%) with asymmetry and facial neurofibroma, as well as three individuals (4%) with overgrowth of the mandible and maxilla, but without further description of the findings. In other craniofacial studies on patients with NF1, hypoplasia of the mandible was recorded far more frequently than hyperplasia (3,7,26). However, in single cases, unilateral hyperplasia of children with NF1 can reach extraordinary dimensions (8,9) and this makes the diagnosis of coincidence with idiopathic mandibular hyperplasia impossible in retrospective evaluation.

Visnapuu et al. described changes in the jaws of 29 out of 102 patients with NF1 (28.4%) (10). This frequency of jaw changes is in the upper range of the registration of spinal changes (scoliosis) in this patient group (1). However, the jaw changes were generally described as relatively mild. Only six patients (5.8%) were found to have facial plexiform neurofibroma obviously in topographic relation to the unilaterally recorded jaw malformations. In these cases, typical alterations of mandibular size and shape were identified ipsilateral to the plexiform neurofibroma. The report describes the barely noticeable mandibular alteration in a 10-year-old, which only became clearly noticeable several years later. The time interval of the conspicuous bone change in that report corresponds to the phase of conspicuous defect formation in the present case. That study was based on the analysis of panoramic views of the jaws; the local tumor burden to be estimated beyond physical inspection remains unknown for most patients.

Malignant peripheral nerve sheath tumor. Malignant peripheral nerve sheath tumors of the craniofacial region are rare (27-34). Sporadic tumors predominate and only rarely are clinical and genetic data available that clarify the syndromic association of the malignancy, presented as case reports (32,33) or reviews (34).

Increase in bone defects associated with DPN are mainly observed in children and adolescents and require clarification (19,33). The bony deformities of the facial skull are often already manifest connately or in early childhood. This early manifestation of skeletal changes in the vicinity of a DPN makes it difficult to analyze which changes are intrinsic malformations of the bone and which are the result of the influence of the neurogenic tumor on bone during development or later in life (33). However, the shape of the jaws of patients with NF1 without FDPN were not found to differ from that of a control group (2,3). An integrated care concept using currently available imaging should be used for diagnosis in these cases (35), which can be supplemented by surgical exploration and advanced tissue analysis (36).

Conclusion

NF1 is a skeletal disease with a highly variable phenotype, including changes in the jaws. The differentiation of a dysplastic defect from tumor erosion and the suspicion of an invasive tumor can be difficult. Surgical measures can remain stable after a long observation period, including augmentation of the mandible after a rapidly occurring bony defect in a mechanically highly stressed area. The occurrence of bone deformities with destruction of the masticatory muscles in this region is striking. It can be assumed that these soft-tissue changes are related to tumorous alteration of the mandibular nerve. Individual variations in skeletal dysplasia in this phenotype may be related to the extent of tumorous changes in the branches of this nerve. The spectrum of histological diagnosis of nerve sheath tumors is large and can reveal different entities and different biological characteristics. Recommendations for a standardized diagnosis of patients with NF1 offer improvements for the appropriate diagnosis and treatment of these patients, whose phenotype often defies simple categorization (37).

Conflicts of Interest

None to declare.

Authors’ Contributions

Reinhard E. Friedrich: Treatment of patient, project administration, conceptualization, investigation, methodology, writing - original draft, writing - review and editing. Felix K. Kohlrusch: Conceptualization, methodology, writing - review and editing. Christian Hagel: Histology, writing - review and editing.

Acknowledgements

The Authors thank the patient for consenting to the publication of this case report.

References

1 Friedman JM Neurofibromatosis 1. In: GeneReviews®. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds.).. Seattle, WA, USA, University of Washington.
2 Friedrich RE Nörnberg LKN & Hagel C Peripheral nerve sheath tumors in patients with neurofibromatosis type 1: Morphological and immunohistochemical study. Anticancer Res. 42(3) 1247 - 1261 2022. DOI: 10.21873/anticanres.15592
3 Friedrich RE Giese M Schmelzle R Mautner VF & Scheuer HA Jaw malformations plus displacement and numerical aberrations of teeth in neurofibromatosis type 1: a descriptive analysis of 48 patients based on panoramic radiographs and oral findings. J Craniomaxillofac Surg. 31(1) 1 - 9 2003. DOI: 10.1016/s1010-5182(02)00160-9
4 Friedrich RE Rother J Christ G Lehmann M Eulenburg CG Giese M & Scheuer HA Analysis of orbital plain radiographs for orbital deformities in neurofibromatosis type 1 patients, with special reference to alterations of the orbital rim as indicators of adjacent plexiform neurofibroma. Anticancer Res. 33(3) 1081 - 1090 2013.
5 Korf BR Plexiform neurofibromas. Am J Med Genet. 89(1) 31 - 37 1999. DOI: 10.1002/(sici)1096-8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w
6 Friedrich RE & Modemann M Neurofibromatosis type 1-associated plexiform neurofibromas of the face and adjacent head regions: topography of lesions and surgical treatment data of 179 patients. J Maxillofac Oral Surg. 22(3) 511 - 524 2023. DOI: 10.1007/s12663-022-01838-8
7 Cohen MM Jr Perspectives on craniofacial asymmetry. Int J Oral Maxillofac Surg. 24(3) 195 - 200 1995. DOI: 10.1016/s0901-5027(06)80126-8
8 Köhler B Neurofibromatose im Kindesalter.. Stuttgart, Germany, Wissenschaftliche Verlagsanstalt. pp.32 63 1990.
9 Mulliken JB Plastic surgery in neurofibromatosis. In: Neurofibromatosis. A Handbook for Patients, Families, and Health-Care Professionals. Rubenstein AE, Korf BR (eds.).. New York, NY, USA, Thieme. pp. 122 1990.
10 Visnapuu V Peltonen S Tammisalo T Peltonen J & Happonen RP Radiographic findings in the jaws of patients with neurofibromatosis 1. J Oral Maxillofac Surg. 70(6) 1351 - 1357 2012. DOI: 10.1016/j.joms.2011.06.204
11 Heine J Über ungewöhnliche Mißbildungen bei Neurofibromatose. Beitr Path Anat. 78 122 - 159 1927.
12 Lohoff W Über Kieferveränderungen und Störungen der Zahnanlage bei Neurofibromatose von Recklinghausen.. Med. Dissertation, Universität zu Köln, Verlag Zaun und Franz Boden.
13 Friedrich RE & Scheuer HA Unilateral creeping destruction of deformed mandibular ramus and angle associated with extensive facial plexiform neurofibroma in neurofibromatosis type 1: a case report with analysis of the literature for diagnosing osteolytic events of the mandible in tumor-suppressor gene syndrome. Anticancer Res. 38(7) 4083 - 4091 2018. DOI: 10.21873/anticanres.12698
14 Stevenson DA Viskochil DH & Carey JC Neurofibromatosis type 1 is a genetic skeletal disorder. Am J Med Genet A. 143A(17) 2082 - 2083 2007. DOI: 10.1002/ajmg.a.31758
15 Elefteriou F Kolanczyk M Schindeler A Viskochil DH Hock JM Schorry EK Crawford AH Friedman JM Little D Peltonen J Carey JC Feldman D Yu X Armstrong L Birch P Kendler DL Mundlos S Yang F Agiostratidou G Hunter-Schaedle K & Stevenson DA Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic options. Am J Med Genet A. 149A(10) 2327 - 2338 2009. DOI: 10.1002/ajmg.a.33045
16 Stevenson DA Schwarz EL Carey JC Viskochil DH Hanson H Bauer S Weng HY Greene T Reinker K Swensen J Chan RJ Yang FC Senbanjo L Yang Z Mao R & Pasquali M Bone resorption in syndromes of the Ras/MAPK pathway. Clin Genet. 80(6) 566 - 573 2011. DOI: 10.1111/j.1399-0004.2010.01619.x
17 Stevenson DA Yan J He Y Li H Liu Y Zhang Q Jing Y Guo Z Zhang W Yang D Wu X Hanson H Li X Staser K Viskochil DH Carey JC Chen S Miller L Roberson K Moyer-Mileur L Yu M Schwarz EL Pasquali M & Yang FC Multiple increased osteoclast functions in individuals with neurofibromatosis type 1. Am J Med Genet A. 155A(5) 1050 - 1059 2011. DOI: 10.1002/ajmg.a.33965
18 Naran S Swanson JW Ligh CA Shubinets V Taylor JA & Bartlett SP Sphenoid dysplasia in neurofibromatosis: patterns of presentation and outcomes of treatment. Plast Reconstr Surg. 142(4) 518e - 526e 2018. DOI: 10.1097/PRS.0000000000004779
19 Jacquemin C Bosley TM Liu D Svedberg H & Buhaliqa A Reassessment of sphenoid dysplasia associated with neurofibromatosis type 1. Am J Neuroradiol. 23(4) 644 - 648 2002.
20 Legius E Messiaen L Wolkenstein P Pancza P Avery RA Berman Y Blakeley J Babovic-Vuksanovic D Cunha KS Ferner R Fisher MJ Friedman JM Gutmann DH Kehrer-Sawatzki H Korf BR Mautner VF Peltonen S Rauen KA Riccardi V Schorry E Stemmer-Rachamimov A Stevenson DA Tadini G Ullrich NJ Viskochil D Wimmer K Yohay K International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC) Huson SM Evans DG & Plotkin SR Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 23(8) 1506 - 1513 2021. DOI: 10.1038/s41436-021-01170-5
21 Hisatomi M Asaumi J Konouchi H Yanagi Y & Kishi K Bone deformity showing a deep coronoid notch of the mandible in a patient with neurofibromatosis type 1. Dentomaxillofac Radiol. 34(6) 380 - 383 2005. DOI: 10.1259/dmfr/46427075
22 Lassmann H Gebhart W & Stockinger L The reaction of connective tissue fibers in the tumor of Recklinghausen’s disease. Virchows Arch B Cell Pathol. 19(2) 167 - 77 1975. DOI: 10.1007/BF02889366
23 Karvonen SL Kallioinen M Ylä-outinen H Pöyhönen M Oikarinen A & Peltonen J Occult neurofibroma and increased S100 protein in the skin of patients with neurofibromatosis type 1. Arch Dermatol. 136(10) 1207 - 9 2000. DOI: 10.1001/archderm.136.10.1207
24 Crowe FW Schull WJ & Neel JV Multiple Neurofibromatosis.. Springfield, Charles C Thomas.
25 Holt JF & Wright EM The radiologic features of neurofibromatosis. Radiology. 51(5) 647 - 664 1948. DOI: 10.1148/51.5.647
26 Gupta SK Nema HV Bhatia PL Sasibabu K & Kesharwani R The radiological features of craniofacial neurofibromatosis. Clin Radiol. 30(5) 553 - 557 1979. DOI: 10.1016/s0009-9260(79)80194-4
27 Liang A Xi B Zhou C Yang Y Zhang J Gui S Xu F & Wan D Malignant peripheral nerve sheath tumor of the trigeminal nerve involving the middle and posterior cranial fossa. World Neurosurg. 112 221 - 226 2018. DOI: 10.1016/j.wneu.2018.01.179
28 Ueda R Saito R Horiguchi T Nakamura Y & Ichikizaki K Malignant peripheral nerve sheath tumor in the anterior skull base associated with neurofibromatosis type 1 - case report. Neurol Med Chir. 44(1) 38 - 42 2004. DOI: 10.2176/nmc.44.38
29 de Oliveira MG Pozatti Moure S Sérgio Batista P Moraes Chaves AC Rados PV & Sant’Ana Filho M NF1 diagnosis criteria and associated sarcomatous tumor review of the literature and case report. Oral Maxillofac Surg. 12(4) 231 - 235 2008. DOI: 10.1007/s10006-008-0137-1
30 Janardhanan M Rakesh S & Vinod Kumar R Intraoral presentation of multiple malignant peripheral nerve sheath tumors associated with neurofibromatosis-1. J Oral Maxillofac Pathol. 15(1) 46 - 51 2011. DOI: 10.4103/0973-029X.80025
31 Oztürk O & Tutkun A A case report of a malignant peripheral nerve sheath tumor of the oral cavity in neurofibromatosis type 1. Case Rep Otolaryngol. 2012 936735 2012. DOI: 10.1155/2012/936735
32 Moreno-Salgado R Rios-Lozano YZ Tamayo-Palacio AC Castillo AI & Hidalgo-Martínez MF Malignant peripheral nerve sheath tumor on a patient with a maternally inherited novel NF1 gene pathogenic germline variant: Case report. Cancer Genetics. 274-275 72 - 74 2023. DOI: 10.1016/j.cancergen.2023.04.003
33 Friedrich RE & Hagel C Malignant peripheral nerve sheath tumor (MPNST) arising from orbital plexiform neurofibroma in a small child with neurofibromatosis type 1. Cancer Diagn Progn. 5(2) 244 - 254 2025.
34 Wilkinson BM Duncan MA Davila R Nicholas B & Babu H Intracranial malignant peripheral nerve sheath tumor: A case report and comprehensive literature review. Surg Neurol Int. 15 101 2024. DOI: 10.25259/SNI_931_2023
35 Ristow I Kaul MG Stark M Zapf A Riedel C Lenz A Mautner VF Farschtschi S Apostolova I Adam G Bannas P Salamon J & Well L Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI. Neurooncol Adv. 6(1) vdae021 2024. DOI: 10.1093/noajnl/vdae021
36 Kresbach C Dottermusch M Eckhardt A Ristow I Paplomatas P Altendorf L Wefers AK Bockmayr M Belakhoua S Tran I Pohl L Neyazi S Bode H Farschtschi S Well L Friedrich RE Reuss D Snuderl M Hagel C Mautner VF & Schüller U Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities. Neuro Oncol. 25(9) 1644 - 1655 2023. DOI: 10.1093/neuonc/noad053
37 Carton C Evans DG Blanco I Friedrich RE Ferner RE Farschtschi S Salvador H Azizi AA Mautner V Röhl C Peltonen S Stivaros S Legius E Oostenbrink R & ERN GENTURIS NF1 Tumour Management Guideline Group ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. EClinicalMedicine. 56 101818 2023. DOI: 10.1016/j.eclinm.2022.101818